Koninklijke Philips (NYSE:PHG – Get Free Report) has earned an average recommendation of “Hold” from the four research firms that are currently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and one has given a buy recommendation to the company.
Several analysts have recently weighed in on the stock. StockNews.com raised shares of Koninklijke Philips from a “buy” rating to a “strong-buy” rating in a report on Thursday. BNP Paribas cut shares of Koninklijke Philips from an “outperform” rating to an “underperform” rating in a research note on Wednesday.
Institutional Trading of Koninklijke Philips
Koninklijke Philips Stock Performance
NYSE PHG opened at $20.60 on Thursday. The firm has a market cap of $19.13 billion, a price-to-earnings ratio of -36.14, a PEG ratio of 0.95 and a beta of 0.90. The company has a 50 day moving average of $22.30 and a 200-day moving average of $21.13. The company has a current ratio of 1.20, a quick ratio of 0.78 and a debt-to-equity ratio of 0.58. Koninklijke Philips has a 1-year low of $15.63 and a 1-year high of $24.27.
Koninklijke Philips Company Profile
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services.
- Five stocks we like better than Koninklijke Philips
- How to Invest in Communication Stocks
- MarketBeat Week in Review – 2/5 – 2/9
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Cloudflare results spark analysts reset: 25% upside ahead
- How to Invest and Trade Chinese Stocks
- Beyond Nvidia: The hidden stars with 200% earnings growth
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.